Revolutionary cancer treatment comes with hefty price tag

Published



A new cancer treatment will be sold for nearly half a million dollars, sparking criticism from some patient advocates.

On Wednesday, the Food and Drug Administration approved the first gene therapy in the U.S. called Kymriah, which customize a patient’s own immune cells to fight a type of leukemia through a therapy called CAR-T.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.